GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Receivable days History
[Consolidated]
Mar2024 | |
---|---|
Receivable days | 128.09 |
What is the latest Receivable days ratio of GUFIC BIOSCIENCES ?
Year | Receivable days |
---|---|
Mar2024 | 128.09 |
How is Receivable days of GUFIC BIOSCIENCES Trending?
Years | Receivable days | % Change | |
---|---|---|---|
Mar2024 | 128.09 | - |
Other Financial Ratios of GUFIC BIOSCIENCES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Receivable days ratio of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹3,847.0 Cr | -4.8% | -10% | 20.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,223.0 Cr | -4.1% | -9.8% | 8.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,610.0 Cr | -2.9% | -0.3% | 63.8% | Stock Analytics | |
CIPLA | ₹119,067.0 Cr | 0.1% | 4.4% | 2.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹102,744.0 Cr | -1.3% | -6.5% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,123.8 Cr | -4% | -5.9% | -7.8% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | -4.8% |
-10% |
20.9% |
SENSEX | -0.8% |
-1.6% |
3.1% |
You may also like the below Video Courses